Uncategorized

Cystic fibrosis is a life-limiting genetic condition that affects over 9000 people in England. Cystic fibrosis is usually diagnosed through […]

Post Content ​ 

Post Content ​ 

Post Content ​ 

Canada’s Drug Agency (CDA-AMC) recommends that Keytruda be reimbursed by public drug plans for the treatment of adult patients with

Immune checkpoint inhibitor–based therapies, especially dual immune checkpoint inhibitor regimens, are now frequently used as initial treatments for advanced or

Sexual dysfunction, including erectile dysfunction (ED) is a common problem for males starting in their early 40s and increases with

Canada’s Drug Agency (CDA-AMC) recommends that Enhertu be reimbursed by public drug plans for the second-line treatment of adult patients

Post Content ​ 

People who receive home- and community-based services (HCBS) have diverse and unique needs that can be met with these services